Emergence of Covid-19 and Increasing Sales of Cold, Flu and Immunity Supplements to Augment Growth of Immune Health Supplements Market

Countries like India, Pakistan, Brazil, Mexico, and Indonesia are seeing major increases in their annual consumption of immune health supplements. It is also common to find these products available at local pharmacies and even at many of the supermarket chains in developed nations like the U.S., U.K., and Australia.

immune-health-supplements-market
Market Dynamics

The immune health supplements market is growing faster than any other sector in pharmaceuticals. This is largely attributed to the emergence of Covid-19. For instance, globally, as of 9:39am CET, 22 December 2020, there have been 76,023,488 confirmed cases of COVID-19, including 1,694,128 deaths, reported to the World Health Organization.

Increasing prevalence of cancer is also expected to aid in growth of the immune health supplements market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Among regions, North America is expected to witness significant growth in the immune health supplements market, owing to increasing sales of cold, flu and immunity supplements. For instance, according to The Nutrition Business Journal, sales of cold, flu and immunity supplements will reach $5.2 billion in 2020, with growth of 51.2% over 2019. Nearly 10% of all U.S. supplement sales in 2020 will be for immune support, emphasizing Americans' interest and confidence in supplements to support their immune health needs.

Increasing awareness regarding flu is expected to offer lucrative growth opportunities for players in the immune health supplements market. For instance, in September 2019, the Wisconsin Department of Health Services (DHS) announced a new community outreach and education funding opportunity for community organizations in order to increase awareness about the flu and the number of Wisconsinites getting flu vaccines.

Competitive Analysis

Key players operating in the immune health supplements market include, EuroPharma, Inc., Glanbia, Plc., Healthycell, Nature's Bounty, Bio Tech Pharmacal, Cellderm Technologies Inc., Bayer AG, Vital Nutrients, NutriGold Inc., Daflorn Ltd., BioGaia, and Seroyal.

Key players operating in the immune health supplements market are focused on launching new products to enhance their market share. For instance, in December 2020, Healthycell launched IMMUNE SUPER BOOST, a new addition to its line of category-leading pill-free supplements, designed to support a strong and resilient immune system. Similarly, in December 2020, Nature's Bounty launched Immune 24 Hour, a supplement that contains the Vitamin C.

In-depth Report on Immune Health Supplements Market by Coherent Market Insights:

https://www.coherentmarketinsights.com/market-insight/immune-health-supplements-market-4065

Location: India

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more